DK1077677T3 - Fremgangsmåde til fremstilling af en biologisk aktiv sammensætning - Google Patents

Fremgangsmåde til fremstilling af en biologisk aktiv sammensætning

Info

Publication number
DK1077677T3
DK1077677T3 DK99927062T DK99927062T DK1077677T3 DK 1077677 T3 DK1077677 T3 DK 1077677T3 DK 99927062 T DK99927062 T DK 99927062T DK 99927062 T DK99927062 T DK 99927062T DK 1077677 T3 DK1077677 T3 DK 1077677T3
Authority
DK
Denmark
Prior art keywords
biologically active
active agent
carrier
preparing
chemical operation
Prior art date
Application number
DK99927062T
Other languages
English (en)
Inventor
Ke Lindahl
H Kan Hagslaett
Catharina Heiman
Rickard Bryland
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of DK1077677T3 publication Critical patent/DK1077677T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK99927062T 1998-05-14 1999-05-12 Fremgangsmåde til fremstilling af en biologisk aktiv sammensætning DK1077677T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (1)

Publication Number Publication Date
DK1077677T3 true DK1077677T3 (da) 2004-02-16

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99927062T DK1077677T3 (da) 1998-05-14 1999-05-12 Fremgangsmåde til fremstilling af en biologisk aktiv sammensætning

Country Status (20)

Country Link
EP (1) EP1077677B1 (da)
JP (1) JP2002514588A (da)
KR (1) KR100766998B1 (da)
CN (1) CN1309554A (da)
AT (1) ATE252371T1 (da)
AU (1) AU742921B2 (da)
CA (1) CA2332110A1 (da)
DE (2) DE69912271T2 (da)
DK (1) DK1077677T3 (da)
ES (1) ES2155049T3 (da)
GR (1) GR20010300014T1 (da)
HU (1) HUP0102002A3 (da)
IL (2) IL139577A0 (da)
NO (1) NO20005725L (da)
NZ (1) NZ508074A (da)
PL (1) PL344221A1 (da)
SE (1) SE9801705D0 (da)
TR (1) TR200003588T2 (da)
WO (1) WO1999058109A1 (da)
ZA (1) ZA200006476B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
EP1651192A1 (en) 2003-08-06 2006-05-03 Nirmal Mulye Pharmaceutical composition containing water soluble drug
JP2009540019A (ja) 2006-06-14 2009-11-19 ドクター・レディーズ・ラボラトリーズ・リミテッド 局所組成物
EP2611852B1 (de) * 2010-08-31 2014-07-30 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
CA2824768A1 (en) * 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
CA2332110A1 (en) 1999-11-18
EP1077677A1 (en) 2001-02-28
NZ508074A (en) 2003-01-31
IL139577A (en) 2007-07-04
AU742921B2 (en) 2002-01-17
ATE252371T1 (de) 2003-11-15
DE69912271D1 (de) 2003-11-27
HUP0102002A2 (hu) 2002-03-28
TR200003588T2 (tr) 2001-06-21
HUP0102002A3 (en) 2002-12-28
NO20005725L (no) 2001-01-11
IL139577A0 (en) 2002-02-10
ZA200006476B (en) 2001-06-11
AU4405199A (en) 1999-11-29
KR20010052349A (ko) 2001-06-25
SE9801705D0 (sv) 1998-05-14
JP2002514588A (ja) 2002-05-21
GR20010300014T1 (en) 2001-04-30
EP1077677B1 (en) 2003-10-22
WO1999058109A1 (en) 1999-11-18
ES2155049T3 (es) 2004-05-16
DE69912271T2 (de) 2004-08-26
ES2155049T1 (es) 2001-05-01
PL344221A1 (en) 2001-10-08
NO20005725D0 (no) 2000-11-13
CN1309554A (zh) 2001-08-22
DE1077677T1 (de) 2001-09-20
KR100766998B1 (ko) 2007-10-15

Similar Documents

Publication Publication Date Title
EA199900143A1 (ru) Способ получения элементов с регулируемым выделением активного компонента
DK0833611T3 (da) Sammensætning omfattende et aktivt middel opløst i en glasdannende bærer og fremgangsmåde til fremstilling heraf
DE59607548D1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
NO954957D0 (no) Synergistisk stabiliserte flytende enzymatiske blandinger
DE59510740D1 (de) Pharmazeutische zubereitung enthaltend metformin und verfahren zu deren herstellung
DK0801559T3 (da) Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum
NO20005725D0 (no) Biologisk aktiv sammensetning
ATE310500T1 (de) Biologisch aktive zusammensetzung
DE50210392D1 (de) Stoffmischung und verfahren zur einbringung mindestens einer feinstteiligen wirkstoffkomponente in ein flüssiges wässriges system
AP9801416A0 (en) Method Of treating a plant disease.
KR880013564A (ko) 마두라마이신의 공급 예비혼합 조성물 및 이에 대한 제조방법
JPS5325267A (en) Removing method for oxygen existing in aqueous system